Bio-Path Holdings (BPTH) Misses Q1 EPS by 20c

Bio-Path Holdings (NASDAQ: BPTH) reported Q1 EPS of ($0.66), $0.20 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• Alpha Cognition Inc (ACOG) PT Raised to $20 at H.C. Wainwright
• H.C. Wainwright Reiterates Buy Rating on Jasper Therapeutics (JSPR)